Table 3. AP incidence in patients after peroral DAE.
Author | Year | N0. of cases | AP after DAE |
---|---|---|---|
Honda et al(9) | 2006 | 13 | 1(7.7%) |
Kopáčová et al(12) | 2007 | 35 | 1(2.9%) |
Aktas et al(14) | 2009 | 135 | 1(0.7%) |
Zepeda-Gómez et al(17) | 2011 | 92 | 3(3.3%) |
Teshima et al(18) | 2012 | 32 | 0(0%) |
Shibuya et al(19) | 2012 | 202 | 0(0%) |
Itaba et al(20) | 2013 | 44 | 1(2.3%) |
Tsujikawa et al(23) | 2015 | 84 | 3(3.6%) |
Kopáčová et al(24) | 2016 | 117 | 0(0%) |
Matsushita et al(25) | 2016 | 96 | 1(1.0%) |